Shipping Alert: Delivery timelines for certain orders may be impacted due to temporary UPS closures.
You Asked. We Listened.
Our Tacrolimus Aqueous Ophthalmic Suspension has been updated with targeted refinements guided by veterinary professionals, including members of our Veterinary Advisory Council, to improve how each drop forms, dispenses, and behaves during administration.
These updates include adjustments to viscosity, reduced foaming, and changes to formulation consistency to support smoother handling and more consistent drop formation.
What Customers Reported in Practice
After the having the opportunity to use the updated formulation, select customers shared:3 of 4
said that bottle pressure felt "just right."
90%
observed drops forming as expected.
2/3
rated the new formula better than previous.
80%
reported no side effects after dosing.
Compounded Preparations
Explore all available options of the new formulation below.
“Pets demonstrated excellent tolerance of this new formula while enhancing ease of administration and compliance for pet owners.”
-Dr. Rob Swinger, DVM, DACVO, Board-Certified Veterinary Ophthalmologist, Medical Director of Elite Veterinary Specialists, and member of Wedgewood's Specialist Customer Council
Quality You Can Count On
Backed by full stability studies and positive user feedback, our improved Tacrolimus Aqueous Ophthalmic Formulation delivers precision and consistency from start to finish.
Every batch is produced in our FDA-registered 503B Outsourcing Facility, upholding the highest manufacturing standards to ensure quality in every preparation.
Additional Resources
Frequently Asked Questions
Why did Wedgewood reformulate Tacrolimus?
We reformulated based on veterinarian and customer feedback to improve viscosity, foaming, and drop consistency, so it's easier to use, more predictable, and better tolerated.
What’s actually different in the new formulation?
The amount of inactive ingredients were adjusted so the medication flows more smoothly from the bottle, produces fewer air bubbles, and delivers a more consistent drop. For formula-specific questions, please call 800.331.8272 to speak to a pharmacist.
What is the Beyond-Use Date?
The current BUD is 150 days. We’re continuing stability testing on the reformulated product, and we expect to extend that as results come back. We chose not to delay access to the improved formulation while testing continues, so you and your clients can start benefiting from it right away.
Why did the price change?
We adjusted pricing to make long-term ophthalmology therapy more accessible for pet owners. These are often lifelong medications, and we wanted to reduce the financial barrier that can get in the way of keeping patients on treatment.
Why is this medication in a clear bottle inside an amber bag?
We use a clear bottle so our pharmacists can visually inspect every compounded product as required by USP guidelines, and we add the amber bag to protect the medication from light and maintain stability.